[1] |
LIANG Si, SHENG Yonghong, LIU Shun, LIU Meiliang, YANG Yu, LEI Lei, WU Lili, ZENG Xiaoyun.
Gene expression profiling of peripheral blood B cells before and after surgery for hepatocellular carcinoma based on single-cell RNA sequencing technology
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 433-.
|
[2] |
CHEN Kun, YANG Hui, LIU Zijia, ZHANG Xiaolin, XU Zhuoyi, LIU Bing, ZHAO Yubao, DING Lu, DENG Yang.
Expression of HLA-DRA protein in hepatocellular carcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(1): 84-89.
|
[3] |
LYU Binghua, ZHONG Luyang, HUANG Qiaoqiao, LI Kezhi, HU Bangli, XIE Mingzhi.
Expression and clinical significance of lncRNA SH3PXD2A-AS1 in colon cancer tissues
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(1): 86-90.
|
[4] |
YANG Shirong, CHEN Yanqin, BAI Xiangyu, GAN Lu, HE Xianl.
Expression and significance of TFB1M in
colorectal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(6): 492-497.
|
[5] |
Tang Yuqi,Yu Hongjing,Shi Lijun,ZouYupeng,Feng Yan,Wang Qi.
Analysis of poor prognosis leaded by CCL18 mediated chemokine network in tumor microenvironment in ovarian cancer patients
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 345-351.
|
[6] |
Liu Lingfeng,Geng Yichao,OuYang Weiwei,Ma Zhu,Li Qingsong,Li Mei, Wang Yu,Luo Daxian,Yang Wengang,Su Shengfa,He Zhixu,Lu bing.
Comparison of clinical efficacy of cisplatin combined with pemetrexed or docetaxel in stage Ⅳ lung adenocarcinoma based on propensity score matching
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 290-294.
|
[7] |
Yi Xuemei,Xue Li,Zhang Jing,Qiao Yujie,Jin Qianqian,Li Hongling.
Expression of nuclear factor erythroid-2-related factor 2 in peripheral T-cell lymphoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(3): 209-212.
|
[8] |
He Pan,Fan Ni,Chen Si,Tang Yanping,Li Kezhi,Yang Chun,Huang Xiaoqing,Cao Ji.
Expression of APOF and IGFALS in primary hepatocellular carcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(3): 212-215.
|
[9] |
Song Yanyan,Gou Wenbin,Zhang Wei.
Expression of CXCR4,PI3K and AKT in MDA-MB?-231 triple-negative breast cancer cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2017, 9(2): 119-123.
|
[10] |
Jia Shouwei,Shao Qiong,Wu Xiaoyan,Cao Li,Long Zijun,Shao Jianyong,Huang Hongbing.
Anaplastic lymphoma kinase gene expression and its clinical significance in hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(6): 354-359.
|
[11] |
Liang Xiaoqin,Wang Zhuo|,Chang Shoufeng,Zhang Xiaoling,Chen Cheng,Wang Jinsui,Su Qinjun.
ROS1 expression in pulmonary adenocarcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(6): 364-368.
|
[12] |
Wang Jianli,He Junkui,Pan Yueqiong,Tang qiaoqiao,Song Honglin.
NF-κB,COX-2 and LKB1 expression in endometrial cancer tissues and clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(5): 278-282.
|
[13] |
Lin Keyu,Su Ying,He Huocong,Zou Changyan,Chen Chao.
Construction of a CNE2 cellular model of nasopharyngeal carcinoma involving β-catenin overexpression
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(4): 201-206.
|
[14] |
Yan Xuemin,Han Zijian,Cai Yan,Yu Zhanpeng,Huang Yuanjiao.
Construction of an EBV-LMP2A eukaryotic expression plasmid with a green fluorescent protein reporter and transfection into nasopharyngeal carcinoma cells
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(4): 207-211.
|
[15] |
Xiang Nana,Zhang Keke.
BRCA1 expression in prostate carcinoma and its clinical significance
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(4): 217-220.
|